International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

The Main Factors Affecting the Tendency for “Injection Drug Use”

Behrooz Hamzeh 1 , Farid Najafi 2 , Fatemeh Heydarpour 1 , Mehdi Moradinazar 1 and Zeinab Moradinazar 3 , *
Authors Information
1 Research Center for Environmental Determinants of Health (RCEDH), Kermanshah University of Medical Sciences, School of Public Health, Kermanshah, IR Iran
2 Social Development and Health Promotion Research Center, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
3 Kermanshah University of Medical Sciences, School of Public Health, Kermanshah, IR Iran
Article information
  • International Journal of High Risk Behaviors and Addiction: September 2018, 7 (3); e12646
  • Published Online: July 24, 2018
  • Article Type: Research Article
  • Received: July 22, 2017
  • Revised: March 4, 2018
  • Accepted: March 11, 2018
  • DOI: 10.5812/ijhrba.12646

To Cite: Hamzeh B, Najafi F, Heydarpour F, Moradinazar M, Moradinazar Z. The Main Factors Affecting the Tendency for “Injection Drug Use”, Int J High Risk Behav Addict. 2018 ; 7(3):e12646. doi: 10.5812/ijhrba.12646.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Boys A, Farrell M, Taylor C, Marsden J, Goodman R, Brugha T, et al. Psychiatric morbidity and substance use in young people aged 13-15 years: results from the Child and Adolescent Survey of Mental Health. Br J Psychiatry. 2003;182:509-17. [PubMed: 12777342].
  • 2. Shargh A, Shakibi A, Nisary R, Alilo A. Survey of related factors with relapse of drug addiction in centers of drug addiction in Western Azarbaijan. J Uromieh Uni Med Sci. 2012;2:129-36.
  • 3. Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med. 2008;5(7). e141. doi: 10.1371/journal.pmed.0050141. [PubMed: 18597549]. [PubMed Central: PMC2443200].
  • 4. Aggleton P, Jenkins P, Malcolm A. HIV/AIDS and injecting drug use: Information, education and communication. Int J Drug Policy. 2005;16:21-30. doi: 10.1016/j.drugpo.2005.02.006.
  • 5. Delgadillo J, Gore S, Ali S, Ekers D, Gilbody S, Gilchrist G, et al. Feasibility randomized controlled trial of cognitive and behavioral interventions for depression symptoms in patients accessing drug and alcohol treatment. J Subst Abuse Treat. 2015;55:6-14. doi: 10.1016/j.jsat.2015.02.008. [PubMed: 25819701].
  • 6. Sanchez JL, Todd CS, Bautista CT, Botros BA, Khakimov MM, Giyasova GM, et al. High HIV prevalence and risk factors among injection drug users in Tashkent, Uzbekistan, 2003-2004. Drug Alcohol Depend. 2006;82 Suppl 1:S15-22. [PubMed: 16769440].
  • 7. Des Jarlais DC, Semaan S. HIV prevention for injecting drug users: the first 25 years and counting. Psychosom Med. 2008;70(5):606-11. doi: 10.1097/PSY.0b013e3181772157. [PubMed: 18519886].
  • 8. Burattini M, Massad E, Rozman M, Azevedo R, Carvalho H. Correlation between HIV and HCV in Brazilian prisoners: evidence for parenteral transmission inside prison. Rev Saude Publica. 2000;34(5):431-6. [PubMed: 11105105].
  • 9. Cocozella DR, Albuquerque MM, Borzi S, Barrio M, Dascenzo V, Santecchia JC, et al. [Prevalence of hepatic involvement, alcoholism, hepatis B, C and HIV in patients with background history of drug use]. Acta Gastroenterol Latinoam. 2003;33(4):177-81. Spanish. [PubMed: 14708468].
  • 10. Mojtahedzadeh V, Razani N, Malekinejad M, Vazirian M, Shoaee S, Saberi Zafarghandi MB, et al. Injection drug use in Rural Iran: integrating HIV prevention into iran's rural primary health care system. AIDS Behav. 2008;12(4 Suppl):S7-12. doi: 10.1007/s10461-008-9408-y. [PubMed: 18521737].
  • 11. Todd CS, Abed AM, Strathdee SA, Scott PT, Botros BA, Safi N, et al. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis. 2007;13(9):1327-31. doi: 10.3201/eid1309.070036. [PubMed: 18252103]. [PubMed Central: PMC2857281].
  • 12. Niknami SH, Hatami A, Heydarnia A. The effect of health educational program on preventing aids in self-reported addicts'wives (Kermanshah 2004). J Kermanshah Univ Med Sci. 2007;11(2).
  • 13. Najarkolaei FR, Niknami S, Shokravi FA, Ahmadi F. Perception and behaviors of HIV/AIDS patients: a qualitative study. J Kermanshah Univ Med Sci. 2009;13(3).
  • 14. Krumm-Merabet C, Meyer TD. Leisure activities, alcohol, and nicotine consumption in people with a hypomanic/hyperthymic temperament. Pers Individ Differ. 2005;38(3):701-12. doi: 10.1016/j.paid.2004.05.024.
  • 15. Aura A, Laatikainen T, Isoaho H, Lazutkina G, Tossavainen K. Adolescents' Attitudes on Smoking Are Related to Experimentation with Smoking, Daily Smoking and Best Friends' Smoking in Two Karelias in Finland and in Russia. Int J Behav Med. 2016;23(6):679-85. doi: 10.1007/s12529-016-9566-7. [PubMed: 27184970].
  • 16. Somani S, Meghani S. Substance Abuse among Youth: A Harsh Reality. Emerg Med. 2016;6(4). doi: 10.4172/2165-7548.1000330.
  • 17. Meymandi M, Ziaeddini H, Yazdi A. Opinion of high school students of Kerman towards affecting factors on narcotics tendency (2005). JQUMS. 2008;12:80-8.
  • 18. Khazaei H, Najafi F, Alavi Far A. Substance abuse prevalence and related factors to it, among students of Kermanshah University of Medical Science in 2011. J Kermanshah Univ Med Sci. 2013;17(3):197-205.
  • 19. Neaigus A, Miller M, Friedman SR, Hagen DL, Sifaneck SJ, Ildefonso G, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction. 2001;96(6):847-60. doi: 10.1080/09652140020050960. [PubMed: 11399216].
  • 20. Abelson J, Treloar C, Crawford J, Kippax S, van Beek I, Howard J. Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction. 2006;101(4):548-55. doi: 10.1111/j.1360-0443.2006.01379.x. [PubMed: 16548934].
  • 21. Fischer B, Manzoni P, Rehm J. Comparing injecting and non-injecting illicit opioid users in a multisite Canadian sample (OPICAN Cohort). Eur Addict Res. 2006;12(4):230-9. doi: 10.1159/000094425. [PubMed: 16968998].
  • 22. Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr. 2006;41(4):493-503. doi: 10.1097/01.qai.0000186391.49205.3b. [PubMed: 16652059].
  • 23. Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002;66(2):189-98. [PubMed: 11906806].
  • 24. Young AM, Havens JR, Leukefeld CG. Route of administration for illicit prescription opioids: a comparison of rural and urban drug users. Harm Reduct J. 2010;7:24. doi: 10.1186/1477-7517-7-24. [PubMed: 20950455]. [PubMed Central: PMC2967505].
  • 25. Strang J, Des Jarlais DC, Griffiths P, Gossop M. The study of transitions in the route of drug use: the route from one route to another. Br J Addict. 1992;87(3):473-83. [PubMed: 1559046].
  • 26. Pavarin RM. Substance use and related problems: a study on the abuse of recreational and not recreational drugs in Northern Italy. Ann Ist Super Sanita. 2006;42(4):477-84. [PubMed: 17361073].
  • 27. Shannon K, Ishida T, Morgan R, Bear A, Oleson M, Kerr T, et al. Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users. Harm Reduct J. 2006;3:1. doi: 10.1186/1477-7517-3-1. [PubMed: 16403229]. [PubMed Central: PMC1368973].
  • 28. Tayeri K, Kasaeian N, Fadaei R, Ataei B. The prevalence of hepatitis B, hepatitis C and associated risk factors in intravenous drug addicts (IVDA) with HIV in Isfahan. 2008.
  • 29. Bird AG, Gore SM, Hutchinson SJ, Lewis SC, Cameron S, Burns S. Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison. BMJ. 1997;315(7099):21-4. [PubMed: 9233321]. [PubMed Central: PMC2127021].
  • 30. Kerr T, Mitra S, Kennedy MC, McNeil R. Supervised injection facilities in Canada: past, present, and future. Harm Reduct J. 2017;14(1):28. doi: 10.1186/s12954-017-0154-1. [PubMed: 28521829]. [PubMed Central: PMC5437687].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments